Volume 4, Issue 3, Page 10 (March 2008)
10 of 37
PREVIEW
FULL TEXT
FULL-TEXT PDF (61 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
For details about the affected lots and the lot numbers of the affected Actavis patches, and a link to the December advisory, see the FDA's MedWatch Web site: www.fda.gov/medwatch/safety/2008/safety08.htm#Duragesic. Adverse reactions should be reported to MedWatch www.fda.gov/medwatch.
PII: S1553-3212(08)70105-5
doi:10.1016/S1553-3212(08)70105-5
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.